June 3, 2016 – Living donors are an increasingly important source of organs for kidney and liver transplantation, giving the world transplant community the responsibility to minimize the benefits to recipients while minimizing the risks to donors. The June issue of Transplantation, the official journal of The Transplantation Society and the International Liver Transplantation Society, brings brought together the most current data and the best analysts to provide a whole issue devoted to living-donor transplantation. The journal is published by Wolters Kluwer.
This special issue presents new research, reviews, and commentaries for an up-to-the-minute look at the present and future of living-donor transplantation. "This issue of Transplantation is dedicated to the approximately 33,000 living kidney and 5,000 living liver donors, as well as the pancreas and bone marrow donors, who provided organs or cells for transplantation across the world last year," comments Prof. Jeremy R. Chapman, Editor-in-Chief of Transplantation. Several papers address ongoing efforts to improve the selection and evaluation of living donors, their surgical and medical care during donation, and lifelong follow-up after the procedure.
"This is all about living donors and their care—providing us all a cause for introspection about what we ask of living donors and our responsibilities to them," says Prof. Chapman. Contributions highlight the complex challenges of collecting long-term information on donor health, including data on the causes of health problems that do occur.
Living-organ donation confronts patients, healthcare professionals, and society with a challenging set of concerns unlike any other type of procedure. "We use global professional guidelines and consensus statements to help clinicians with this complex area of clinical practice," Prof. Chapman comments. The special issue publishes the evidence base for the KDIGO guidelines on evaluation and follow-up care of living kidney donors, currently under development. To enhance the international debate, it provides a thoughtful insider's update on Iran's controversial paid living organ donation program.
While living-donor liver transplantation (LDLT) accounts for less than five percent of liver transplants in the United States and Europe, it has become the principal form of liver transplantation worldwide. The special issue presents the International Liver Transplantation Society guideline on LDLT, as well as a summary of recent UK guidelines. A special article highlights the promising experience with LDLT in Latin America, while acknowledging the numerous challenges that remain
A special review marks the 50th anniversary of the original Ciba symposium examining ethical and legal issues in transplantation—"Since that time, much has changed and much has remained the same," Prof. Chapman reflects. The special issue rounds out the topics by presenting new data on the long-term outcomes of living pancreas donors and the safety systems established for hematopoietic stem cell transplant donors.
Prof. Chapman adds, "This issue will provide food for thought for everyone involved in living-donor organ transplantation: donor, recipient, physician, surgeon, transplant nurse, patient association, transplant coordinator, public policy analyst, lawmaker and, most importantly, the families who share the burden of decision-making."
Click here to read this special issue.
###
About TransplantationThe official journal of The Transplantation Society, and the International Liver Transplantation Society, Transplantation is published monthly and is the most cited and influential journal in the field, with more than 25,000 citations a year. The journal will see 50 years in 2016. Transplantation has been the trusted source for extensive and timely coverage of the most important advances in transplantation.
About Wolters KluwerWolters Kluwer is a global leader in professional information services. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance and healthcare rely on Wolters Kluwer's market leading information-enabled tools and software solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.
Wolters Kluwer reported 2015 annual revenues of €4.2 billion. The group serves customers in over 180 countries, and employs over 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
For more information about our products and organization, visit www.wolterskluwerhealth.com, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.
RSS